Ladenburg Thalmann Starts Inhibikase Therapeutics Inc (IKT) at Buy Mar 4, 2026 06:36AM
Inhibikase prices $100 million stock offering at $1.45 per share Nov 20, 2025 09:54PM
Inhibikase Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock and Pre-Funded Warrants Nov 20, 2025 09:54PM
Inhibikase Therapeutics announces public offering of stock Nov 20, 2025 04:12PM
Inhibikase Therapeutics announces public offering of stock Nov 20, 2025 04:12PM


Nov 20, 2025 04:12PM Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants